https://orcid.org/0000-0002-4183-5333
References
- Xue J, Lam JM. Granuloma annulare. Paediatr Child Health. 2019;24:366–367. doi:10.1093/pch/pxz003
- Barbieri JS, Rodriguez O, Rosenbach M, et al. Incidence and prevalence of granuloma annulare in the United States. JAMA Dermatol. 2021;157(7):1–8. doi:10.1001/jamadermatol.2021.1847
- Joshi TP, Chen V, Dong JL, et al. Psychiatric comorbidities associated with granuloma annulare: a case control study in the all of us database. J Am Acad Dermatol. 2022;87(3):e119–e120. doi:10.1016/j.jaad.2022.05.056
- Barbieri JS, Rosenbach M, Rodriguez O, et al. Association of granuloma annulare with type 2 diabetes, hyperlipidemia, autoimmune disorders, and hematologic malignant neoplasms. JAMA Dermatol. 2021;157(7):817–823. doi:10.1001/jamadermatol.2021.1805
- Sumikawa Y, Ansai S, Kimura T, et al. Interstitial type granuloma annulare associated with Sjogren’s syndrome. J Dermatol. 2010;37:493–495. doi:10.1111/j.1346-8138.2010.00865.x
- Sakiyama T, Hirai I, Konohana A, et al. Interstitial-type granuloma annulare associated with Sjögren syndrome. J Dtsch Dermatol Ges. 2014;12(5):415–416.
- Corrà A, Quintarelli L, Verdelli A, et al. Granulomatous dermatitis and systemic disease: an association to consider. Biomed Res Int. 2020;2020:3281380. doi:10.1155/2020/3281380
- Pontarini E, Verstappen GM, Grigoriadou S, et al. Blocking T cell co-stimulation in primary Sjögren’s syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers. Clin Exp Rheumatol. 2020;126:222–227.
- Min MS, Wu JN, He H, et al. Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways. J Am Acad Dermatol. 2020;83(1):63–70. doi:10.1016/j.jaad.2019.12.028
- Wang Y, Wu YT, Zheng ZC, et al. Interstitial granulomatous dermatitis associated with primary biliary cirrhosis. J Dermatol. 2018;45(1):112–113. doi:10.1111/1346-8138.13778